NR 293 Midterm Exam
I I I
1. A Inurse Iis Icaring Ifor Ia I4-year-old Ichild Iwho Iis Iresistant Ito Itaking Imedication. IWhich Iof
Ithe Ifollowing Istrategies Ishould Ithe Inurse Iuse Ito Ielicit Ithe Ichild’s Icooperation?
a. Offer Ithe Ichild Ia Ichoice Iof Itaking Ithe Imedication Iwith Ijuice Ior Iwater
b. Tell Ithe Ichild Iit Iis Icandy
c. Hide Ithe Imedications Iin Ia Ilarge Idish Iof Iice Icream
d. Tell Ithe Ichild Ihe Iwill Ihave Ia Ishot Iinstead
2. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Idifficulty Iswallowing Imedications Iand Iis Iprescribed
Ienteric-coated Iaspirin IPO Ionce Idaily. IThe Iclient Iasks Iif Ithe Imedication Ican Ibe Icrushed Ito
Imake Iit Ieasier Ito Iswallow. IWhich Iof Ithe Ifollowing Iresponses Ishould Ithe Inurse Iprovide?
a. "Crushing Ithe Imedication Imight Icause Iyou Ito Ihave Ia Istomachache Ior Iindigestion.
i. Rationale: IThe Ipill Iis Ienteric-coated Ito Iprevent Ibreakdown Iin Ithe Istomach
Iand Idecrease Ithe Ipossibility Iof IGI Idistress. ICrushing Idestroys Iprotection.
b. "Crushing Ithe Imedication Iis Ia Igood Iidea, Iand II Ican Imix Iit Iin Isome Iice Icream Ifor
Iyou.”
c. "Crushing Ithe Imedication Iwould Irelease Iall Ithe Imedication Iat Ionce, Irather Ithan
Iover Itime."
d. "Crushing Iis Iunsafe, Ias Iit Idestroys Ithe Iingredients Iin Ithe Imedication."
3. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Icongestive Iheart Ifailure Iand Iis Itaking Idigoxin Idaily.
IThe Iclient Irefused Ibreakfast Iand Iis Icomplaining Iof Inausea Iand Iweakness. IWhich Iof Ithe
Ifollowing Iactions Ishould Ithe Inurse Itake Ifirst?
a. A. ICheck Ithe Iclient's Ivital Isigns.
i. Rationale: IIt Iis Ipossible Ithat Ithe Iclient's Inausea Iis Isecondary Ito Idigoxin
Itoxicity. IAssess Ifor Ibradycardia, Ia Isymptom Iof Idigoxin Itoxicity. IThe Inurse
Ishould Iwithhold Ithe Imedication Iand Icall Ithe Iprovider Iif Ithe Iclient's Iheart
Irate Iis Iless Ithan I60 Ibpm.
b. Request Ia Idietitian Iconsult.
c. Suggest Ithat Ithe Iclient Irests Ibefore Ieating Ithe Imeal.
d. Request Ian Iorder Ifor Ian Iantiemetic.
4. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ithrombophlebitis Iand Iis Ireceiving Iheparin Iby
Icontinuous IIV Iinfusion. IThe Iclient Iasks Ithe Inurse Ihow Ilong Iit Iwill Itake Ifor Ithe Iheparin Ito
Idissolve Ithe Iclot. IWhich Iof Ithe Ifollowing Iresponses Ishould Ithe Inurse Igive?
a. "It Iusually Itakes Iheparin Iat Ileast I2 Ito I3 Idays Ito Ireach Ia Itherapeutic Iblood Ilevel."
b. "A Ipharmacist Iis Ithe Iperson Ito Ianswer Ithat Iquestion."
c. "Heparin Idoes Inot Idissolve Iclots. IIt Istops Inew Iclots Ifrom Iforming."
i. Rationale: IThis Istatement Iaccurately Ianswers Ithe Iclient's Iquestion.
d. "The Ioral Imedication Iyou Iwill Itake Iafter Ithis IIV Iwill Idissolve Ithe Iclot.
5. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ibipolar Idisorder Iand Ihas Ibeen Itaking Ilithium Ifor I1
Iyear. IBefore Iadministering Ithe Imedication, Ithe Inurse Ishould Icheck Ito Isee Ithat Iwhich Iof Ithe
Ifollowing Itests Ihave Ibeen Icompleted?
a. Thyroid Ihormone Iassay
i. Rationale: IThyroid Itesting Iis Iimportant Ibecause Ilong-term Iuse Iof Ilithium
Imay Ilead Ito Ithyroid Idysfunction.
b. Liver Ifunction Itests:
i. Rationale: ILFTs Imust Ibe Imonitored Ibefore Iand Iduring Ivalproic Iacid
Itherapy
c. Erythrocyte Isedimentation Irate
, i. Rationale: IThis Iis Inot Ia Inecessary Itest Irelated Ito Ilithium Itherapy.
d. Brain Inatriuretic Ipeptide
6. A Inurse Iis Iproviding Idischarge Iteaching Ito Ia Iclient Iwho Ihas Iasthma Iand Inew Iprescriptions
Ifor Icromolyn Iand Ialbuterol, Iboth Iby Inebulizer. IWhich Iof Ithe Ifollowing Istatements Iby Ithe
Iclient Iindicates Ian Iunderstanding Iof Ithe Iteaching?
a. “If Imy Ibreathing Ibegins Ito Ifeel Itight, II Iwill Iuse Ithe Icromolyn Iimmediately.”
b. “I Iwill Ibe Isure Ito Itake Ithe Ialbuterol Ibefore Itaking Ithe Icromolyn.”
i. Rationale: IThe Iclient Ishould Ialways Iuse Ithe Ibronchodilator I(albuterol)
Iprior Ito Iusing Ithe Ileukotriene Imodifier I(cromolyn). IUsing Ithe
Ibronchodilator Ifirst Iallows Ithe Iairways Ito Ibe Iopened, Iensuring Ithat
ItheImaximum Idose Iof Imedication Iwill Iget Ito Ithe Iclient's Ilungs.
c. “I Iwill Iuse Iboth Imedications Iimmediately Iafter Iexercising.”
d. “I Iwill Iadminister Ithe Imedications I10 Iminutes Iapart.”
7. A Inurse Iis Icompleting Ia Imedication Ihistory Ifor Ia Iclient Iwho Ireports Iusing Iover-the-
Icounter Icalcium Icarbonate Iantacid. IWhich Iof Ithe Ifollowing Irecommendations Ishould Ithe
Inurse Imake Iabout Itaking Ithis Imedication?
a. Decrease Ibulk Iin Ithe Idiet Ito Icounteract Ithe Iadverse Ieffect Iof Idiarrhea.
b. Take Ithe Imedication Iwith Idairy Iproducts Ito Iincrease Iabsorption.
c. Reduce Isodium Iintake.
d. Drink Ia Iglass Iof Iwater Iafter Itaking Ithe Imedication.
i. Calcium Icarbonate Iis Ia Idietary Isupplement Iused Iwhen Ithe Iamount Iof
Icalcium Itaken Iin Ithe Idiet Iis Inot Ienough. ICalcium Icarbonate Imay Ialso Ibe
Iused Ias Ian Iantacid Ito Irelieve Iheartburn, Iacid Iindigestion, Iand Istomach
Iupset. IThe Iclient Ishould Idrink Ia Ifull Iglass Iof Iwater Iafter Itaking Ian Iantacid
Ito Ienhance Iits Ieffectiveness.
8. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ideep Ivein Ithrombosis Iand Ihas Ibeen Ion Iheparin
Icontinuous Iinfusion Ifor I5 Idays. IThe Iprovider Iprescribes Iwarfarin IPO Iwithout
Idiscontinuing Ithe Iheparin. IThe Iclient Iasks Ithe Inurse Iwhy Iboth Ianticoagulants Iare
Inecessary. IWhich Iof Ithe Ifollowing Istatements Ishould Ithe Inurse Imake?
a. "Warfarin Itakes Iseveral Idays Ito Iwork, Iso Ithe IIV Iheparin Iwill Ibe Iused Iuntil Ithe
Iwarfarin Ireaches Ia Itherapeutic Ilevel."
i. Rationale: IHowever, Ithese Imedications Iwork Iin Idifferent Iways Ito Iachieve
Itherapeutic Icoagulation Iand Imust Ibe Igiven Itogether Iuntil Itherapeutic
IlevelsIof Ianticoagulation Ican Ibe Iachieved Iby Iwarfarin Ialone, Iwhich Iis
Iusually Iwithin I1 Ito I5 Idays. IWhen Ithe Iclient's IPT Iand IINR Iare Iwithin
Itherapeutic Irange, Ithe Iheparin Ican Ibe Idiscontinued.
b. "I Iwill Icall Ithe Iprovider Ito Iget Ia Iprescription Ifor Idiscontinuing Ithe IIV Iheparin
Itoday.”
c. "Both Iheparin Iand Iwarfarin Iwork Itogether Ito Idissolve Ithe Iclots."
d. "The IIV Iheparin Iincreases Ithe Ieffects Iof Ithe Iwarfarin Iand Idecreases Ithe Ilength Iof
Iyour Ihospital Istay."
9. A Inurse Iis Iproviding Iteaching Ito Ia Iclient Iwho Ihas Iasthma Iand Ia Inew Iprescription Ifor
Iinhaled Ibeclomethasone. IWhich Iof Ithe Ifollowing Iinstructions Ishould Ithe Inurse Iprovide?
a. Check Ithe Ipulse Iafter Imedication Iadministration.
b. Take Ithe Imedication Iwith Imeals.
c. C. IRinse Ithe Imouth Iafter Iadministration.
, i. Rationale: IUse Iof Iglucocorticoids Iby Imetered Idose Iinhaler Ican Iallow Ia
Ifungal Iovergrowth Iin Ithe Imouth. IRinsing Ithe Imouth Iafter Iadministration
Ican Ilessen Ithe Ilikelihood Iof Ithis Icomplication.
d. Limit Icaffeine Iintake.
10. A Inurse Iis Iteaching Ia Iclient Iwho Ihas Ia Inew Iprescription Ifor Icolchicine Ito Itreat Igout. IWhich
Iof Ithe Ifollowing Iinstructions Ishould Ithe Inurse Iinclude?
a. "Take Ithis Imedication Iwith Ifood Iif Inausea Idevelops."
b. B. I"Monitor Ifor Imuscle Ipain."
i. Rationale: IThis Imedication Ican Icause Irhabdomyolysis. IThe Iclient Ishould
Imonitor Iand Ireport Imuscle Ipain.
c. "Expect Ito Ihave Iincreased Ibruising."
d. "Increase Iyour Iintake Iof Igrapefruit Ijuice”
11. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Iactive Ipulmonary Ituberculosis I(TB) Iand Iis Ito Ibe
Istarted Ion Iintravenous Irifampin Itherapy. IThe Inurse Ishould Iinstruct Ithe Iclient Ithat Ithis
Imedication Ican Icause Iwhich Iof Ithe Ifollowing Iadverse Ieffects?
a. Constipation
b. Black Icolored Istools
c. Staining Iof Iteeth
d. Body Isecretions Iturning Ia Ired-orange Icolor
i. Rationale: IRifampin Iis Iused Iin Icombination Iwith Iother Imedicines Ito Itreat
ITB. IRifampin Iwill Icause Ithe Iurine, Istool, Isaliva, Isputum, Isweat, Iand Itears
Ito Iturn Ireddish-orange Ito Ireddish-brown.
12. A Inurse Icaring Ifor Ia Iclient Iwho Ihas Ihypertension Iand Iasks Ithe Inurse Iabout Ia Iprescription
Ifor Ipropranolol. IThe Inurse Ishould Iinform Ithe Iclient Ithat Ithis Imedication Iis Icontraindicated
Iin Iclients Iwho Ihave Ia Ihistory Iof Iwhich Iof Ithe Ifollowing Iconditions?
a) Asthma
1. Rationale: IPropranolol, Ia Ibeta-blocker, Iis Icontraindicated Iin Iclients Iwho
Ihave Iasthma Ibecause Iit Ican Icause Ibronchospasms. IPropranolol Iblocks
ItheIsympathetic Istimulation, Iwhich Iprevents Ismooth Imuscle Irelaxation.
b) Glaucoma
c) Depression
d) Migraines
I I I
1. A Inurse Iis Icaring Ifor Ia I4-year-old Ichild Iwho Iis Iresistant Ito Itaking Imedication. IWhich Iof
Ithe Ifollowing Istrategies Ishould Ithe Inurse Iuse Ito Ielicit Ithe Ichild’s Icooperation?
a. Offer Ithe Ichild Ia Ichoice Iof Itaking Ithe Imedication Iwith Ijuice Ior Iwater
b. Tell Ithe Ichild Iit Iis Icandy
c. Hide Ithe Imedications Iin Ia Ilarge Idish Iof Iice Icream
d. Tell Ithe Ichild Ihe Iwill Ihave Ia Ishot Iinstead
2. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Idifficulty Iswallowing Imedications Iand Iis Iprescribed
Ienteric-coated Iaspirin IPO Ionce Idaily. IThe Iclient Iasks Iif Ithe Imedication Ican Ibe Icrushed Ito
Imake Iit Ieasier Ito Iswallow. IWhich Iof Ithe Ifollowing Iresponses Ishould Ithe Inurse Iprovide?
a. "Crushing Ithe Imedication Imight Icause Iyou Ito Ihave Ia Istomachache Ior Iindigestion.
i. Rationale: IThe Ipill Iis Ienteric-coated Ito Iprevent Ibreakdown Iin Ithe Istomach
Iand Idecrease Ithe Ipossibility Iof IGI Idistress. ICrushing Idestroys Iprotection.
b. "Crushing Ithe Imedication Iis Ia Igood Iidea, Iand II Ican Imix Iit Iin Isome Iice Icream Ifor
Iyou.”
c. "Crushing Ithe Imedication Iwould Irelease Iall Ithe Imedication Iat Ionce, Irather Ithan
Iover Itime."
d. "Crushing Iis Iunsafe, Ias Iit Idestroys Ithe Iingredients Iin Ithe Imedication."
3. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Icongestive Iheart Ifailure Iand Iis Itaking Idigoxin Idaily.
IThe Iclient Irefused Ibreakfast Iand Iis Icomplaining Iof Inausea Iand Iweakness. IWhich Iof Ithe
Ifollowing Iactions Ishould Ithe Inurse Itake Ifirst?
a. A. ICheck Ithe Iclient's Ivital Isigns.
i. Rationale: IIt Iis Ipossible Ithat Ithe Iclient's Inausea Iis Isecondary Ito Idigoxin
Itoxicity. IAssess Ifor Ibradycardia, Ia Isymptom Iof Idigoxin Itoxicity. IThe Inurse
Ishould Iwithhold Ithe Imedication Iand Icall Ithe Iprovider Iif Ithe Iclient's Iheart
Irate Iis Iless Ithan I60 Ibpm.
b. Request Ia Idietitian Iconsult.
c. Suggest Ithat Ithe Iclient Irests Ibefore Ieating Ithe Imeal.
d. Request Ian Iorder Ifor Ian Iantiemetic.
4. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ithrombophlebitis Iand Iis Ireceiving Iheparin Iby
Icontinuous IIV Iinfusion. IThe Iclient Iasks Ithe Inurse Ihow Ilong Iit Iwill Itake Ifor Ithe Iheparin Ito
Idissolve Ithe Iclot. IWhich Iof Ithe Ifollowing Iresponses Ishould Ithe Inurse Igive?
a. "It Iusually Itakes Iheparin Iat Ileast I2 Ito I3 Idays Ito Ireach Ia Itherapeutic Iblood Ilevel."
b. "A Ipharmacist Iis Ithe Iperson Ito Ianswer Ithat Iquestion."
c. "Heparin Idoes Inot Idissolve Iclots. IIt Istops Inew Iclots Ifrom Iforming."
i. Rationale: IThis Istatement Iaccurately Ianswers Ithe Iclient's Iquestion.
d. "The Ioral Imedication Iyou Iwill Itake Iafter Ithis IIV Iwill Idissolve Ithe Iclot.
5. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ibipolar Idisorder Iand Ihas Ibeen Itaking Ilithium Ifor I1
Iyear. IBefore Iadministering Ithe Imedication, Ithe Inurse Ishould Icheck Ito Isee Ithat Iwhich Iof Ithe
Ifollowing Itests Ihave Ibeen Icompleted?
a. Thyroid Ihormone Iassay
i. Rationale: IThyroid Itesting Iis Iimportant Ibecause Ilong-term Iuse Iof Ilithium
Imay Ilead Ito Ithyroid Idysfunction.
b. Liver Ifunction Itests:
i. Rationale: ILFTs Imust Ibe Imonitored Ibefore Iand Iduring Ivalproic Iacid
Itherapy
c. Erythrocyte Isedimentation Irate
, i. Rationale: IThis Iis Inot Ia Inecessary Itest Irelated Ito Ilithium Itherapy.
d. Brain Inatriuretic Ipeptide
6. A Inurse Iis Iproviding Idischarge Iteaching Ito Ia Iclient Iwho Ihas Iasthma Iand Inew Iprescriptions
Ifor Icromolyn Iand Ialbuterol, Iboth Iby Inebulizer. IWhich Iof Ithe Ifollowing Istatements Iby Ithe
Iclient Iindicates Ian Iunderstanding Iof Ithe Iteaching?
a. “If Imy Ibreathing Ibegins Ito Ifeel Itight, II Iwill Iuse Ithe Icromolyn Iimmediately.”
b. “I Iwill Ibe Isure Ito Itake Ithe Ialbuterol Ibefore Itaking Ithe Icromolyn.”
i. Rationale: IThe Iclient Ishould Ialways Iuse Ithe Ibronchodilator I(albuterol)
Iprior Ito Iusing Ithe Ileukotriene Imodifier I(cromolyn). IUsing Ithe
Ibronchodilator Ifirst Iallows Ithe Iairways Ito Ibe Iopened, Iensuring Ithat
ItheImaximum Idose Iof Imedication Iwill Iget Ito Ithe Iclient's Ilungs.
c. “I Iwill Iuse Iboth Imedications Iimmediately Iafter Iexercising.”
d. “I Iwill Iadminister Ithe Imedications I10 Iminutes Iapart.”
7. A Inurse Iis Icompleting Ia Imedication Ihistory Ifor Ia Iclient Iwho Ireports Iusing Iover-the-
Icounter Icalcium Icarbonate Iantacid. IWhich Iof Ithe Ifollowing Irecommendations Ishould Ithe
Inurse Imake Iabout Itaking Ithis Imedication?
a. Decrease Ibulk Iin Ithe Idiet Ito Icounteract Ithe Iadverse Ieffect Iof Idiarrhea.
b. Take Ithe Imedication Iwith Idairy Iproducts Ito Iincrease Iabsorption.
c. Reduce Isodium Iintake.
d. Drink Ia Iglass Iof Iwater Iafter Itaking Ithe Imedication.
i. Calcium Icarbonate Iis Ia Idietary Isupplement Iused Iwhen Ithe Iamount Iof
Icalcium Itaken Iin Ithe Idiet Iis Inot Ienough. ICalcium Icarbonate Imay Ialso Ibe
Iused Ias Ian Iantacid Ito Irelieve Iheartburn, Iacid Iindigestion, Iand Istomach
Iupset. IThe Iclient Ishould Idrink Ia Ifull Iglass Iof Iwater Iafter Itaking Ian Iantacid
Ito Ienhance Iits Ieffectiveness.
8. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Ideep Ivein Ithrombosis Iand Ihas Ibeen Ion Iheparin
Icontinuous Iinfusion Ifor I5 Idays. IThe Iprovider Iprescribes Iwarfarin IPO Iwithout
Idiscontinuing Ithe Iheparin. IThe Iclient Iasks Ithe Inurse Iwhy Iboth Ianticoagulants Iare
Inecessary. IWhich Iof Ithe Ifollowing Istatements Ishould Ithe Inurse Imake?
a. "Warfarin Itakes Iseveral Idays Ito Iwork, Iso Ithe IIV Iheparin Iwill Ibe Iused Iuntil Ithe
Iwarfarin Ireaches Ia Itherapeutic Ilevel."
i. Rationale: IHowever, Ithese Imedications Iwork Iin Idifferent Iways Ito Iachieve
Itherapeutic Icoagulation Iand Imust Ibe Igiven Itogether Iuntil Itherapeutic
IlevelsIof Ianticoagulation Ican Ibe Iachieved Iby Iwarfarin Ialone, Iwhich Iis
Iusually Iwithin I1 Ito I5 Idays. IWhen Ithe Iclient's IPT Iand IINR Iare Iwithin
Itherapeutic Irange, Ithe Iheparin Ican Ibe Idiscontinued.
b. "I Iwill Icall Ithe Iprovider Ito Iget Ia Iprescription Ifor Idiscontinuing Ithe IIV Iheparin
Itoday.”
c. "Both Iheparin Iand Iwarfarin Iwork Itogether Ito Idissolve Ithe Iclots."
d. "The IIV Iheparin Iincreases Ithe Ieffects Iof Ithe Iwarfarin Iand Idecreases Ithe Ilength Iof
Iyour Ihospital Istay."
9. A Inurse Iis Iproviding Iteaching Ito Ia Iclient Iwho Ihas Iasthma Iand Ia Inew Iprescription Ifor
Iinhaled Ibeclomethasone. IWhich Iof Ithe Ifollowing Iinstructions Ishould Ithe Inurse Iprovide?
a. Check Ithe Ipulse Iafter Imedication Iadministration.
b. Take Ithe Imedication Iwith Imeals.
c. C. IRinse Ithe Imouth Iafter Iadministration.
, i. Rationale: IUse Iof Iglucocorticoids Iby Imetered Idose Iinhaler Ican Iallow Ia
Ifungal Iovergrowth Iin Ithe Imouth. IRinsing Ithe Imouth Iafter Iadministration
Ican Ilessen Ithe Ilikelihood Iof Ithis Icomplication.
d. Limit Icaffeine Iintake.
10. A Inurse Iis Iteaching Ia Iclient Iwho Ihas Ia Inew Iprescription Ifor Icolchicine Ito Itreat Igout. IWhich
Iof Ithe Ifollowing Iinstructions Ishould Ithe Inurse Iinclude?
a. "Take Ithis Imedication Iwith Ifood Iif Inausea Idevelops."
b. B. I"Monitor Ifor Imuscle Ipain."
i. Rationale: IThis Imedication Ican Icause Irhabdomyolysis. IThe Iclient Ishould
Imonitor Iand Ireport Imuscle Ipain.
c. "Expect Ito Ihave Iincreased Ibruising."
d. "Increase Iyour Iintake Iof Igrapefruit Ijuice”
11. A Inurse Iis Icaring Ifor Ia Iclient Iwho Ihas Iactive Ipulmonary Ituberculosis I(TB) Iand Iis Ito Ibe
Istarted Ion Iintravenous Irifampin Itherapy. IThe Inurse Ishould Iinstruct Ithe Iclient Ithat Ithis
Imedication Ican Icause Iwhich Iof Ithe Ifollowing Iadverse Ieffects?
a. Constipation
b. Black Icolored Istools
c. Staining Iof Iteeth
d. Body Isecretions Iturning Ia Ired-orange Icolor
i. Rationale: IRifampin Iis Iused Iin Icombination Iwith Iother Imedicines Ito Itreat
ITB. IRifampin Iwill Icause Ithe Iurine, Istool, Isaliva, Isputum, Isweat, Iand Itears
Ito Iturn Ireddish-orange Ito Ireddish-brown.
12. A Inurse Icaring Ifor Ia Iclient Iwho Ihas Ihypertension Iand Iasks Ithe Inurse Iabout Ia Iprescription
Ifor Ipropranolol. IThe Inurse Ishould Iinform Ithe Iclient Ithat Ithis Imedication Iis Icontraindicated
Iin Iclients Iwho Ihave Ia Ihistory Iof Iwhich Iof Ithe Ifollowing Iconditions?
a) Asthma
1. Rationale: IPropranolol, Ia Ibeta-blocker, Iis Icontraindicated Iin Iclients Iwho
Ihave Iasthma Ibecause Iit Ican Icause Ibronchospasms. IPropranolol Iblocks
ItheIsympathetic Istimulation, Iwhich Iprevents Ismooth Imuscle Irelaxation.
b) Glaucoma
c) Depression
d) Migraines
